Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Tumor Ablation Market, by Treatment
1.4.2 Europe Tumor Ablation Market, by Technology
1.4.3 Europe Tumor Ablation Market, by Application
1.4.4 Europe Tumor Ablation Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers : Jan 2016 - Oct 2019) Leading Players
Chapter 4. Europe Tumor Ablation Market by Treatment
4.1 Europe Surgical Ablation Market by Country
4.2 Europe Laparoscopic Ablation Market by Country
4.3 Europe Percutaneous Ablation Market by Country
Chapter 5. Europe Tumor Ablation Market by Technology
5.1 Europe Radiofrequency Ablation Market by Country
5.2 Europe Microwave Ablation Market by Country
5.3 Europe Cryoablation Market by Country
5.4 Europe Irreversible Electroporation Market by Country
5.5 Europe Other Technology Market by Country
Chapter 6. Europe Tumor Ablation Market by Application
6.1 Europe Liver Cancer Market by Country
6.2 Europe Breast Cancer Market by Country
6.3 Europe Lung Cancer Market by Country
6.4 Europe Kidney Cancer Market by Country
6.5 Europe Prostate Cancer Market by Country
6.6 Europe Others Cancer Market by Country
Chapter 7. Europe Tumor Ablation Market by Country
7.1 Germany Tumor Ablation Market
7.1.1 Germany Tumor Ablation Market by Treatment
7.1.2 Germany Tumor Ablation Market by Technology
7.1.3 Germany Tumor Ablation Market by Application
7.2 UK Tumor Ablation Market
7.2.1 UK Tumor Ablation Market by Treatment
7.2.2 UK Tumor Ablation Market by Technology
7.2.3 UK Tumor Ablation Market by Application
7.3 France Tumor Ablation Market
7.3.1 France Tumor Ablation Market by Treatment
7.3.2 France Tumor Ablation Market by Technology
7.3.3 France Tumor Ablation Market by Application
7.4 Russia Tumor Ablation Market
7.4.1 Russia Tumor Ablation Market by Treatment
7.4.2 Russia Tumor Ablation Market by Technology
7.4.3 Russia Tumor Ablation Market by Application
7.5 Spain Tumor Ablation Market
7.5.1 Spain Tumor Ablation Market by Treatment
7.5.2 Spain Tumor Ablation Market by Technology
7.5.3 Spain Tumor Ablation Market by Application
7.6 Italy Tumor Ablation Market
7.6.1 Italy Tumor Ablation Market by Treatment
7.6.2 Italy Tumor Ablation Market by Technology
7.6.3 Italy Tumor Ablation Market by Application
7.7 Rest of Europe Tumor Ablation Market
7.7.1 Rest of Europe Tumor Ablation Market by Treatment
7.7.2 Rest of Europe Tumor Ablation Market by Technology
7.7.3 Rest of Europe Tumor Ablation Market by Application
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 Johnson and Johnson (Ethicon, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.1 Recent strategies and developments:
8.2.1.1 Acquisition and Mergers:
8.2.1.2 Product Launches and Product Expansions:
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Misonix, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 EDAP TMS S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Theraclion SA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Partnerships, Collaborations, and Agreements:
8.7 AngioDynamics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Mermaid Medical A/S
8.8.1 Company Overview
8.9 HealthTronics, Inc. (Altaris Capital Partners, LLC)
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.9.2.2 Partnerships, Collaborations, and Agreements:
8.1 SonaCare Medical, LLC
8.10.1 Company overview
Unique Offerings 